We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Arix Bioscience Plc | LSE:ARIX | London | Ordinary Share | GB00BD045071 | ORD 0.001P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 142.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Arix Bioscience PLC (ARIX) Director/PDMR Shareholding 28-Oct-2022 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.
-----------------------------------------------------------------------------------------------------------------------
Arix Bioscience plc ("Company")
Director/PDMR Shareholding
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
The Company has been notified that Peregrine Moncreiffe, Director and Chairman of the Company purchased 50,000 Ordinary shares of 0.001 pence each in the Company ("Shares") on 26 October 2022 at a price of 1.04 pence per share and a further purchase of 25,000 shares at a price of 1.04 pence per share on 27 October 2022.
1 Details of the person discharging managerial responsibilities / person closely associated a) Name Peregrine Moncreiffe 2 Reason for the notification a) Position/status Non-Executive Director and Chair of the Board b) Initial notification /Amendment Initial Notification 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Arix Bioscience plc b) LEI 213800OVT3AHQCXNIX43 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of the financial instrument, type of Arix Bioscience plc Ordinary shares of 0.001 pence instrument each Identification code GB00BD045071 b) Nature of the transaction Share purchase Price(s) and volume(s) Price Volume(s) (s) 50,000 c) 1.04 25,000 1.04 Aggregated information d) - Aggregated volume 75,000 - Price GBP78,000 e) Date of the transaction 26 October 2022 27 October 2022 f) Place of the transaction Outside a trading venue
For further information please contact: Kin Company Secretarial Limited, Company Secretary +44 20 8819 6486
-----------------------------------------------------------------------------------------------------------------------
ISIN: GB00BD045071 Category Code: DSH TIDM: ARIX LEI Code: 213800OVT3AHQCXNIX43 OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State Sequence No.: 197341 EQS News ID: 1474001 End of Announcement EQS News Service =------------------------------------------------------------------------------------
Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1474001&application_name=news
(END) Dow Jones Newswires
October 28, 2022 02:00 ET (06:00 GMT)
1 Year Arix Bioscience Chart |
1 Month Arix Bioscience Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions